Bioxytran BIXT
OTC BIXT
$0.02 +0.00 (+0.00%)
At close: Oct 1, 2026 · 4:00 PM EDT

Bioxytran (BIXT) Return on Capital Employed [ROCE] (2011 - 2017)

Updated

Bioxytran (BIXT) recorded Return on Capital Employed [ROCE] of -963.54% in Q4 2017.

Analysis

Bioxytran (BIXT) Return on Capital Employed [ROCE] (2011 - 2017) Analysis & Trends

For FY2017, Bioxytran reported Return on Capital Employed [ROCE] of -1269.18%.

  • Annual Return on Capital Employed [ROCE] has a five-year change of -345.50 percentage points (FY2012 to FY2017).
  • Across earlier years, Return on Capital Employed [ROCE] came in at -1229.35% in FY2013 (-305.68 pp).
  • The Q4 2017 figure is the highest quarterly Return on Capital Employed [ROCE] since Q1 2014.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 46.74%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 17.83%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 17.92%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 6.28%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 19.32%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 9.54%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 16.66%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -5.97%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 11.86%
10 Bioxytran 2.29 Mn 1.13 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2017 -963.54%
Mar 31, 2014 -946.86%
Dec 31, 2013 -2,927.51%
Mar 31, 2013 -1,725.90%
Dec 31, 2012 -964.83%
Jun 30, 2012 -2,047.44%
Mar 31, 2012 -2,746.15%
Dec 31, 2011 -2,360.71%
Sep 30, 2011 -900.15%
API Access

Bioxytran Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=BIXT&period=max&api_key=YOUR_API_KEY